Confirming you are not from the U.S. or the Philippines

By giving this statement, I explicitly declare and confirm that:
  • I am not a U.S. citizen or resident
  • I am not a resident of the Philippines
  • I do not directly or indirectly own more than 10% of shares/voting rights/interest of the U.S. residents and/or do not control U.S. citizens or residents by other means
  • I am not under the direct or indirect ownership of more than 10% of shares/voting rights/interest and/or under the control of U.S. citizen or resident exercised by other means
  • I am not affiliated with U.S. citizens or residents in terms of Section 1504(a) of FATCA
  • I am aware of my liability for making a false declaration.
For the purposes of this statement, all U.S. dependent countries and territories are equalled to the main territory of the USA. I accept full responsibility for the accuracy of this declaration and commit to personally address and resolve any claims or issues that may arise from a breach of this statement.
We are dedicated to your privacy and the security of your personal information. We only collect emails to provide special offers and important information about our products and services. By submitting your email address, you agree to receive such letters from us. If you want to unsubscribe or have any questions or concerns, write to our Customer Support.
Back

EUR/JPY Price Analysis: Further rangebound likely

  • EUR/JPY extends the choppy activity around 130.00 so far this week.
  • The mid-128.00s should hold the initial test if the downside picks up pace.

EUR/JPY keeps the consolidative mood unchanged around the 130.00 area for yet another session.

Extra consolidation appears on the cards in the very near term ahead of the FOMC event. On the downside, decent contention is located in the 128.50 region, which is also reinforced by a Fibo level (128.54) and the 200-day SMA (128.53).

In the meantime, while above the 200-day SMA at 128.53, the outlook for EUR/JPY is expected to remain constructive.

EUR/JPY daily chart

 

Pfizer R&D Chief: Third dose may be needed within 6-12 months after full vaccination

Pfizer's Research and Development Chief says they continue to believe it is likely that a third dose booster may be needed within six to 12 months aft
Read more Previous

US Dollar Index Price Analysis: Minor support emerges at 92.30

DXY leaves the recent weakness and manages to post decent gains in the 92.50/60 region on Wednesday. Further rangebound around current levels is likel
Read more Next